Operational Medicine Test and Evaluation Cell Salvage Supplemental - (AFMEDCOM)
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
FA8003 771 ENTERPRISE SOURCING SQ
Contract Value
Not provided
Codes & Classification
Solicitation Number
FA800326SS004
NAICS
339112 - Surgical and Medical Instrument Manufacturing
Classification Code
-
Additional Details
Documents2
The Operational Medicine Test and Evaluation Cell Salvage Supplemental (AFMEDCOM) notice, identified by procurement number FA800326SS004, is a Sources Sought Request for Information (RFI) issued by the federal contracting office FA8003 771 Enterprise Sourcing Squadron. The primary objective of this market research initiative is to identify innovative solutions capable of safely bridging the time to surgery in austere environments, specifically through the development and deployment of devices for cell salvage, blood conditioning, and autonomous blood return with flow rate control. The scope of this RFI encompasses not only commercially available products but also prototypes that demonstrate these capabilities.
The government seeks to assess the marketplace for devices that can perform cell salvage and blood conditioning, with the added requirement of autonomous return and precise flow rate control of blood delivery. This is particularly critical for operational medicine scenarios where immediate access to surgical intervention is limited, and effective blood management can significantly impact patient outcomes. The intended outcome is to gather comprehensive information on available technologies and services that meet these requirements, thereby informing future procurement strategies and potential solicitations.
All business sizes, including large enterprises and all categories of small businesses, are encouraged to respond, reflecting the government's commitment to inclusivity and broad industry engagement. The relevant North American Industry Classification System (NAICS) code for this requirement is 339112, which pertains to Surgical and Medical Instrument Manufacturing. This classification underscores the technical and manufacturing expertise sought for this initiative.
The contracting entity, FA8003 771 Enterprise Sourcing Squadron, operates as a federal office and is responsible for managing this market research effort. Interested parties may direct inquiries and submit responses to Mr. Aaron Nelson, the designated primary contact, via email at [email protected] or by phone at 301-619-8601. The notice remains active, with a response deadline set for November 16, 2026.
It is important to note that responses to this RFI are strictly for informational purposes and do not constitute offers; they cannot be accepted by the government to form binding contracts. Contractors should be aware that this is a preliminary step in the procurement process, intended to inform future requirements and potential solicitations. The opportunity is listed on SAM.gov under Opportunity ID 2ec1cc3030c24f609ccb0da368b04e8b, where additional attachments may be available for review.
In summary, this notice represents a strategic effort by the U.S. Air Force Medical Command to identify and evaluate advanced medical device solutions for operational medicine in challenging environments. Contractors with relevant expertise in surgical and medical instrument manufacturing, particularly those capable of delivering cell salvage and blood conditioning technologies, are encouraged to participate and contribute to shaping the future of military medical support.